DK0572437T3 - 2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkning - Google Patents
2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkningInfo
- Publication number
- DK0572437T3 DK0572437T3 DK92903632.5T DK92903632T DK0572437T3 DK 0572437 T3 DK0572437 T3 DK 0572437T3 DK 92903632 T DK92903632 T DK 92903632T DK 0572437 T3 DK0572437 T3 DK 0572437T3
- Authority
- DK
- Denmark
- Prior art keywords
- antitumor action
- enhancing antitumor
- diaminoquinazoline derivatives
- diaminoquinazoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65792291A | 1991-02-20 | 1991-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0572437T3 true DK0572437T3 (da) | 1995-07-03 |
Family
ID=24639196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92903632.5T DK0572437T3 (da) | 1991-02-20 | 1992-01-08 | 2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkning |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0572437B1 (da) |
JP (1) | JPH06500117A (da) |
KR (1) | KR930703270A (da) |
CN (1) | CN1064271A (da) |
AT (1) | ATE121735T1 (da) |
AU (1) | AU655798B2 (da) |
BR (1) | BR9205645A (da) |
CA (1) | CA2101542A1 (da) |
CZ (1) | CZ387292A3 (da) |
DE (2) | DE69202243T2 (da) |
DK (1) | DK0572437T3 (da) |
ES (1) | ES2071484T3 (da) |
FI (1) | FI933656A (da) |
HU (1) | HUT64755A (da) |
IE (1) | IE920522A1 (da) |
IL (1) | IL100942A0 (da) |
MX (1) | MX9200675A (da) |
NO (1) | NO932954L (da) |
NZ (1) | NZ241627A (da) |
PT (1) | PT100132A (da) |
WO (1) | WO1992014716A1 (da) |
YU (1) | YU17092A (da) |
ZA (1) | ZA921911B (da) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9300059D0 (en) * | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
ES2049659B1 (es) * | 1992-10-08 | 1994-10-16 | Ici Plc | Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. |
GB9323290D0 (en) * | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
GB9314893D0 (en) * | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
IL112249A (en) | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
DE4429026C2 (de) * | 1994-08-16 | 1995-11-16 | Mueller Wolfgang | Inlay-Entfernungsinstrumentarium für Totalendoprothese |
GB9424233D0 (en) * | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
GB9508537D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
GB9508565D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
AU5343096A (en) * | 1995-04-27 | 1996-11-18 | Zeneca Limited | Quinazoline derivatives |
GB9508535D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivative |
AU7692896A (en) * | 1995-12-01 | 1997-06-27 | Novartis Ag | Quinazolin-2,4-diazirines as NPY receptor antagonist |
GB9624482D0 (en) * | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
SK285141B6 (sk) | 1996-02-13 | 2006-07-07 | Astrazeneca Uk Limited | Použitie chinazolínového derivátu, chinazolínový derivát, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje |
GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9607729D0 (en) * | 1996-04-13 | 1996-06-19 | Zeneca Ltd | Quinazoline derivatives |
GB9707800D0 (en) | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
ATE398120T1 (de) | 1999-11-05 | 2008-07-15 | Astrazeneca Ab | Neue quinazolin-derivate |
AU2001240150A1 (en) * | 2000-03-13 | 2001-09-24 | Chemrx Advanced Technologies, Inc. | Quinazoline synthesis |
EP1274692B1 (en) | 2000-04-07 | 2006-08-02 | AstraZeneca AB | Quinazoline compounds |
WO2003055866A1 (en) * | 2001-12-21 | 2003-07-10 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
EP1660092A2 (en) * | 2003-07-03 | 2006-05-31 | Myriad Genetics, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
JP2007269629A (ja) * | 2004-06-21 | 2007-10-18 | Astellas Pharma Inc | キナゾリン誘導体 |
CA2573103A1 (en) * | 2004-07-06 | 2006-02-09 | Angion Biomedica Corporation | Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer |
EP1833482A4 (en) * | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
WO2006074187A2 (en) * | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Method of treating brain cancer |
WO2007065913A1 (en) * | 2005-12-07 | 2007-06-14 | Neurosearch A/S | Novel quinazoline-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
CN101100466B (zh) | 2006-07-05 | 2013-12-25 | 天津和美生物技术有限公司 | 不可逆蛋白质酪氨酸磷酰化酶抑制剂及其制备和应用 |
WO2008086462A2 (en) * | 2007-01-11 | 2008-07-17 | Wyeth | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS |
WO2009001060A2 (en) * | 2007-06-27 | 2008-12-31 | Summit Corporation Plc | Use of compounds for preparing anti-tuberculosis agents |
EP2566480A4 (en) * | 2010-05-07 | 2014-03-19 | California Inst Of Techn | METHOD AND COMPOSITIONS FOR INHIBITING THE VALOSIN-CONTAINING PROTEIN |
WO2018212774A1 (en) * | 2017-05-17 | 2018-11-22 | Vanderbilt University | Quinazoline compounds as modulators of ras signaling |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663706A (en) * | 1969-09-29 | 1972-05-16 | Pfizer | Use of 2,4-diaminoquinazolines as hypotensive agents |
IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
AU610328B2 (en) * | 1987-12-03 | 1991-05-16 | Smithkline Beckman Intercredit B.V. | 2,4- diaminoquinazoline derivatives |
-
1992
- 1992-01-08 DK DK92903632.5T patent/DK0572437T3/da active
- 1992-01-08 EP EP92903632A patent/EP0572437B1/en not_active Expired - Lifetime
- 1992-01-08 CZ CS923872A patent/CZ387292A3/cs unknown
- 1992-01-08 DE DE69202243T patent/DE69202243T2/de not_active Expired - Fee Related
- 1992-01-08 WO PCT/US1992/000028 patent/WO1992014716A1/en active IP Right Grant
- 1992-01-08 KR KR1019930702481A patent/KR930703270A/ko not_active Application Discontinuation
- 1992-01-08 DE DE9290018U patent/DE9290018U1/de not_active Expired - Lifetime
- 1992-01-08 CA CA002101542A patent/CA2101542A1/en not_active Abandoned
- 1992-01-08 ES ES92903632T patent/ES2071484T3/es not_active Expired - Lifetime
- 1992-01-08 AT AT92903632T patent/ATE121735T1/de not_active IP Right Cessation
- 1992-01-08 HU HU9302384A patent/HUT64755A/hu unknown
- 1992-01-08 BR BR9205645A patent/BR9205645A/pt not_active Application Discontinuation
- 1992-01-08 JP JP4503777A patent/JPH06500117A/ja active Pending
- 1992-01-08 AU AU11848/92A patent/AU655798B2/en not_active Expired - Fee Related
- 1992-02-13 IL IL100942A patent/IL100942A0/xx unknown
- 1992-02-17 NZ NZ241627A patent/NZ241627A/xx unknown
- 1992-02-18 PT PT100132A patent/PT100132A/pt not_active Application Discontinuation
- 1992-02-18 MX MX9200675A patent/MX9200675A/es unknown
- 1992-02-19 IE IE052292A patent/IE920522A1/en not_active Application Discontinuation
- 1992-02-19 ZA ZA921191A patent/ZA921911B/xx unknown
- 1992-02-19 CN CN92101113A patent/CN1064271A/zh active Pending
- 1992-02-19 YU YU17092A patent/YU17092A/sh unknown
-
1993
- 1993-08-19 FI FI933656A patent/FI933656A/fi not_active Application Discontinuation
- 1993-08-19 NO NO93932954A patent/NO932954L/no unknown
Also Published As
Publication number | Publication date |
---|---|
FI933656A0 (fi) | 1993-08-19 |
NO932954D0 (no) | 1993-08-19 |
MX9200675A (es) | 1992-08-01 |
FI933656A (fi) | 1993-08-19 |
EP0572437B1 (en) | 1995-04-26 |
DE9290018U1 (de) | 1993-10-14 |
IE920522A1 (en) | 1992-08-26 |
DE69202243D1 (de) | 1995-06-01 |
JPH06500117A (ja) | 1994-01-06 |
AU655798B2 (en) | 1995-01-12 |
CA2101542A1 (en) | 1992-08-21 |
CZ387292A3 (en) | 1994-04-13 |
AU1184892A (en) | 1992-09-15 |
DE69202243T2 (de) | 1995-08-31 |
BR9205645A (pt) | 1994-06-07 |
NZ241627A (en) | 1993-06-25 |
ES2071484T3 (es) | 1995-06-16 |
ZA921911B (en) | 1993-08-19 |
HUT64755A (en) | 1994-02-28 |
CN1064271A (zh) | 1992-09-09 |
EP0572437A1 (en) | 1993-12-08 |
PT100132A (pt) | 1993-05-31 |
ATE121735T1 (de) | 1995-05-15 |
NO932954L (no) | 1993-08-19 |
YU17092A (sh) | 1994-12-28 |
KR930703270A (ko) | 1993-11-29 |
WO1992014716A1 (en) | 1992-09-03 |
HU9302384D0 (en) | 1993-11-29 |
IL100942A0 (en) | 1992-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0572437T3 (da) | 2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkning | |
YU47993B (sh) | Derivati 2,4-diaminohinazolina | |
ATE225341T1 (de) | In 6-position durch thio substituierte paclitaxele | |
YU39992A (sh) | Derivati 2,4-diaminopirimidina | |
DE59006859D1 (de) | Bohrtisch. | |
MX9200725A (es) | Tratamiento de cancer esofagico. tratamiento de cancer esofagico. | |
RU93054001A (ru) | 2,4-диаминохиназолиновые производные, способ их получения фармацевтическая композиция, способ ингибирования р-гликопротеина | |
ATE110135T1 (de) | Bohrtisch. | |
GR1001394B (el) | Παράγωγα 4-[4-[4-(4-υδροξυφαινυλ)-1-πιπεραζινυλ] φαινυλ]-5-με?υλ3Η-1,2,4-τριαζολ-3-όνης. | |
GR1001386B (el) | Ετεροκυκλικές ενώσεις. | |
MA21976A1 (fr) | Le robinet economiseur . |